Stockholm bourse opens lower; AstraZeneca outperforms on rate, oil pressure

Swedish equities opened the week lower as rising market interest rates and higher oil prices dampened risk appetite. AstraZeneca, a defensive pharmaceutical name, outperformed the broader market. The move reflects a broader risk-off tone driven by macro headwinds rather than company-specific news.